Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hyaluronic acid + triamcinolone hexacetonide
- Development stage
- Unknown
- Lead developer
- Anika Therapeutics
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Intraarticular
01
Overview
This combination therapy for knee osteoarthritis involves the intra-articular injection of hyaluronic acid (specifically the brand Osteonil) and the corticosteroid triamcinolone hexacetonide. Hyaluronic acid acts as a viscosupplement, restoring the viscoelastic properties of synovial fluid to provide lubrication and shock absorption. Triamcinolone hexacetonide is a potent anti-inflammatory corticosteroid that provides rapid pain relief. The University of Sao Paulo General Hospital conducted a Phase 4 study (NCT01813565) to determine the optimal dosing regimen (single vs. multiple injections) for this combination, aiming to improve clinical outcomes as measured by VAS, WOMAC, and Lequesne scores.
- Brand names
- Osteonil
- Other names
- viscosupplementation 1+1+1viscosupplementation 3 at onceviscosupplementation3 at onceviscosupplementation-3 at once
02
Targets
CD44 (CD44 antigen)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on hyaluronic acid + triamcinolone hexacetonide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hyaluronic acid + triamcinolone hexacetonide.